DK0879051T3 - Hastighedskontrolleret transdermal indgivelse af risperidon - Google Patents

Hastighedskontrolleret transdermal indgivelse af risperidon

Info

Publication number
DK0879051T3
DK0879051T3 DK96908146T DK96908146T DK0879051T3 DK 0879051 T3 DK0879051 T3 DK 0879051T3 DK 96908146 T DK96908146 T DK 96908146T DK 96908146 T DK96908146 T DK 96908146T DK 0879051 T3 DK0879051 T3 DK 0879051T3
Authority
DK
Denmark
Prior art keywords
risperidone
rate
transdermal administration
controlled transdermal
controlled
Prior art date
Application number
DK96908146T
Other languages
Danish (da)
English (en)
Inventor
Jean Louis Mesens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of DK0879051T3 publication Critical patent/DK0879051T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK96908146T 1995-04-06 1996-03-29 Hastighedskontrolleret transdermal indgivelse af risperidon DK0879051T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95200867 1995-04-06
PCT/EP1996/001421 WO1996031201A1 (en) 1995-04-06 1996-03-29 Rate-controlled transdermal administration of risperidone

Publications (1)

Publication Number Publication Date
DK0879051T3 true DK0879051T3 (da) 2003-09-29

Family

ID=8220172

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96908146T DK0879051T3 (da) 1995-04-06 1996-03-29 Hastighedskontrolleret transdermal indgivelse af risperidon

Country Status (17)

Country Link
EP (1) EP0879051B9 (zh)
JP (1) JPH11503138A (zh)
KR (1) KR100437672B1 (zh)
AR (1) AR003413A1 (zh)
AT (1) ATE242631T1 (zh)
CA (1) CA2214420A1 (zh)
CY (1) CY2388B1 (zh)
DE (1) DE69628672T2 (zh)
DK (1) DK0879051T3 (zh)
ES (1) ES2201176T3 (zh)
HK (1) HK1015681A1 (zh)
HR (1) HRP960154A2 (zh)
IL (1) IL117809A (zh)
PT (1) PT879051E (zh)
TW (1) TW592729B (zh)
WO (1) WO1996031201A1 (zh)
ZA (1) ZA962752B (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10042412B4 (de) * 2000-08-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Abgabe von Venlafaxin, und seine Verwendung
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
EP1661560B1 (en) * 2004-11-22 2008-11-05 Hisamitsu Pharmaceutical Co., Inc. Transdermal patch comprising a melting point lowering agent
EP1857103B1 (en) * 2005-02-28 2018-10-24 Hisamitsu Pharmaceutical Co., Inc. Transdermally absorbable preparation
US20070134310A1 (en) * 2005-09-23 2007-06-14 Nedberge Diane E Transdermal risperidone delivery system
RU2445959C2 (ru) 2006-06-09 2012-03-27 ДАЙНИППОН СУМИТОМО ФАРМА Ко., ЛТД. Новый лейкопластырный препарат
DE102007006244B4 (de) 2007-02-08 2012-03-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System zur Verabreichung wasserlöslicher Wirkstoffe
US8927537B2 (en) * 2007-12-21 2015-01-06 Nuvo Research Inc. Patches, formulations, and associated methods for transdermal delivery of alprazolam and other drugs
WO2010098261A1 (ja) * 2009-02-24 2010-09-02 久光製薬株式会社 リスペリドン含有経皮吸収型製剤及びこれを用いた貼付剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
US4710191A (en) * 1985-12-16 1987-12-01 Jonergin, Inc. Therapeutic device for the administration of medicaments
US4938759A (en) * 1986-09-02 1990-07-03 Alza Corporation Transdermal delivery device having a rate controlling adhesive
US5788983A (en) * 1989-04-03 1998-08-04 Rutgers, The State University Of New Jersey Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
DE69025943T2 (de) * 1989-08-21 1996-09-19 Beth Israel Hospital Verwendung von Spiperone-derivate zur Immunosuppression

Also Published As

Publication number Publication date
AR003413A1 (es) 1998-08-05
HK1015681A1 (en) 1999-10-22
IL117809A0 (en) 1996-08-04
TW592729B (en) 2004-06-21
AU696789B2 (en) 1998-09-17
JPH11503138A (ja) 1999-03-23
KR100437672B1 (ko) 2004-09-10
HRP960154A2 (en) 1997-08-31
ZA962752B (en) 1997-10-06
CY2388B1 (en) 2004-09-10
DE69628672T2 (de) 2004-04-29
CA2214420A1 (en) 1996-10-10
PT879051E (pt) 2003-10-31
AU5149296A (en) 1996-10-23
DE69628672D1 (de) 2003-07-17
ES2201176T3 (es) 2004-03-16
ATE242631T1 (de) 2003-06-15
EP0879051B1 (en) 2003-06-11
IL117809A (en) 2000-10-31
EP0879051A1 (en) 1998-11-25
WO1996031201A1 (en) 1996-10-10
EP0879051B9 (en) 2004-03-03

Similar Documents

Publication Publication Date Title
DE69628448D1 (de) Transdermale verabreichungsform von flurbiprofen
DE19681287T1 (de) Orale Formulierung von 2-Methylthienobenzodiazepin
EE9700241A (et) Farmatseutiline kompositsioon transdermaalseks manustamiseks
DK42093D0 (da) Administrationsmetode
ATE200864T1 (de) Tablette mit gesteuerter freisetzung von alfuzosinhydrochlorid
IS5245A (is) Lyfjablanda úr ómeprasól
DK0851855T3 (da) Derivater af melatonin deraf som lægemiddel
DE69530004D1 (de) Transdermale verabreichung von apomorphin
FI972292A0 (fi) Administrering av diabetes
DE69218932D1 (de) Transdermale therapeutische Formulierung
NO982809L (no) Prolegemidler av tombin-inhibitorer
NO980146L (no) Epidural administrering av terapeutiske forbindelser med vedvarende frigjöringshastighet
DE69429359D1 (de) Orale zubereitungen von antimykotika
DE69633333D1 (de) Diphosphonatderivate von therapeutischen substanzen
PT769965E (pt) Formulacoes aquosas de risperidona
NO973471D0 (no) Transdermal formulering
DK0879051T3 (da) Hastighedskontrolleret transdermal indgivelse af risperidon
BR9607722A (pt) Formulação transdérmica
EE9700207A (et) Teraapias kasutatavad bitsüklilised amidiini derivaadid
DK104389A (da) Anvendelse af imidazolderivater
DK104489A (da) Anvendelse af triazolderivater
DK0842148T3 (da) Derivater af benzensulfonamid, deres fremstilling og deres terapeutiske anvendelse
DK0869952T3 (da) Derivater af 5-naphthalen-1-yl-1,3-dioxaner, fremstilling og terapeutisk anvendelse heraf
DE69722623D1 (de) Verabreichungssystem von funktionellen wirkstoffen
DK0866699T3 (da) Anvendelse af cholinesteraseinhibitorer til fremstilling af et medikament til behandling af xerostomi